These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32089294)

  • 61. Exposure at home to airborne concentrations of nitrogen mustard during topical application for the treatment of mycosis fungoides: a case study.
    Snell J; Lillquist DR; Lewis-Younger C; Wallace DO
    Dermatology; 2000; 200(2):124-8. PubMed ID: 10773700
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Precautions for personnel applying topical nitrogen mustard to patients with mycosis fungoides.
    Thestrup-Pedersen K; Christiansen JV; Zachariae H
    Dermatologica; 1982 Aug; 165(2):108-13. PubMed ID: 7141061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study.
    Correia E; Krishnasamy S; Suriano JG; Shi W; Alpdogan SO; Sahu J; Porcu P; Nikbakht N
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):581-588. PubMed ID: 35393251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term topical nitrogen mustard treatment does not induce pulmonary fibrosis in MF patients.
    Nielsen M; Rasmussen K; Knudsen N; Thestrup-Pedersen K
    Acta Derm Venereol; 1994 Jan; 74(1):70-1. PubMed ID: 7908491
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Contact urticaria and anaphylactic reactions induced by topical application of nitrogen mustard].
    Sánchez Yus E; Surárez Martín E
    Actas Dermosifiliogr; 1977; 68(12):39-44. PubMed ID: 140594
    [No Abstract]   [Full Text] [Related]  

  • 66. Scandinavian mycosis fungoides trial.
    Thomsen K
    Cancer Treat Rep; 1979 Apr; 63(4):709-11. PubMed ID: 445520
    [No Abstract]   [Full Text] [Related]  

  • 67. [Topical chemotherapy in mycosis fungoides (author's transl)].
    Touraine R; Revuz J
    Dermatologica; 1978; 157(6):397-406. PubMed ID: 363476
    [No Abstract]   [Full Text] [Related]  

  • 68. Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions.
    Koumourtzis M; Lampadaki K; Dalamaga M; Papadavid E
    Acta Derm Venereol; 2022 Jun; 102():adv00730. PubMed ID: 35199177
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A case of CD56+ mycosis fungoides.
    Klekotka PA; Faulkner-Jones B; Heffernan MP
    Arch Dermatol; 2006 Oct; 142(10):1370-2. PubMed ID: 17043207
    [No Abstract]   [Full Text] [Related]  

  • 70. Ointment-based mechlorethamine treatment for mycosis fungoides.
    Price NM; Hoppe RT; Deneau DG
    Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Topical treatment of early cutaneous T-cell lymphoma.
    Ramsay DL; Meller JA; Zackheim HS
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
    Van Scott EJ; Kalmanson JD
    Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
    [No Abstract]   [Full Text] [Related]  

  • 73. Treatment of CD30-Negative Refractory Mycosis Fungoides With Brentuximab Vedotin.
    Zhang C; Chairatchaneeboon M; Haun P; Landsburg D; Kim EJ
    JAMA Dermatol; 2018 Jan; 154(1):109-110. PubMed ID: 29167875
    [No Abstract]   [Full Text] [Related]  

  • 74. A 30-year history of CD4+ vesiculo-bullous mycosis fungoides and multiple visceral malignancies.
    Pearce A; Reid C; Gramp A; Sidhu S
    Australas J Dermatol; 2007 Feb; 48(1):46-9. PubMed ID: 17222304
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Topical chlormethine gel in the treatment of mycosis fungoides: A single-center real-life experience and systematic review of the literature.
    Laghi A; Franceschini C; Mandel VD; Teoli M; Musicco F; Sansone M; La Malfa AM; Ardigò M
    Dermatol Ther; 2022 Sep; 35(9):e15683. PubMed ID: 35778940
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Coexistent B-cell lymphoma and cutaneous T-cell lymphoma.
    Inokuchi T; Shincho M; Moriwaki Y; Ka T; Takahashi S; Tsutsumi Z; Lin Y; Hirota S; Yamamoto T
    Intern Med; 2006; 45(9):641-7. PubMed ID: 16755097
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.
    Querfeld C; Scarisbrick JJ; Assaf C; Guenova E; Bagot M; Ortiz-Romero PL; Quaglino P; Bonizzoni E; Hodak E
    Dermatology; 2022; 238(2):347-357. PubMed ID: 34091453
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
    du Vivier A; Vollum DI
    Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
    [TBL] [Abstract][Full Text] [Related]  

  • 79. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Poikilodermatous mycosis fungoides.
    Farley-Loftus R; Mandal R; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.